
0:41
Single-speaker YouTube excerpt (Dr. Charles Mok) discussing testosterone use in women. The speaker reports observational findings from other countries that women on combined testosterone and estrogen had substantially lower breast cancer rates (estimated 30–70% fewer cases), describes pharmaceutical development of a testosterone patch for female sexual dysfunction, and criticizes an FDA advisory panel (noting its all-male membership) for rejecting the product over alleged heart disease and cancer risks—claims the speaker says were incorrect, asserting testosterone is cardioprotective and protective against breast cancer.










